Literature DB >> 31915890

[Systematic evidence analysis for comparison of MRI-targeted biopsy versus systematic biopsy in the diagnosis of prostate cancer].

A Sigle1, C A Jilg1, S Schmidt2, A Miernik3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31915890     DOI： 10.1007/s00120-019-01102-x

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  17 in total

1.  Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.

Authors:  Saiful Miah; David Eldred-Evans; Lucy A M Simmons; Taimur T Shah; Abi Kanthabalan; Manit Arya; Mathias Winkler; Neil McCartan; Alex Freeman; Shonit Punwani; Caroline M Moore; Mark Emberton; Hashim U Ahmed
Journal:  J Urol       Date:  2018-06-27       Impact factor: 7.450

2.  Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.

Authors:  Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis
Journal:  Radiology       Date:  2016-04-01       Impact factor: 11.105

3.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.

Authors:  Frank-Jan H Drost; Daniël F Osses; Daan Nieboer; Ewout W Steyerberg; Chris H Bangma; Monique J Roobol; Ivo G Schoots
Journal:  Cochrane Database Syst Rev       Date:  2019-04-25

4.  Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.

Authors:  Marloes van der Leest; Erik Cornel; Bas Israël; Rianne Hendriks; Anwar R Padhani; Martijn Hoogenboom; Patrik Zamecnik; Dirk Bakker; Anglita Yanti Setiasti; Jeroen Veltman; Huib van den Hout; Hans van der Lelij; Inge van Oort; Sjoerd Klaver; Frans Debruyne; Michiel Sedelaar; Gerjon Hannink; Maroeska Rovers; Christina Hulsbergen-van de Kaa; Jelle O Barentsz
Journal:  Eur Urol       Date:  2018-11-23       Impact factor: 20.096

5.  Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Authors:  Olivier Rouvière; Philippe Puech; Raphaële Renard-Penna; Michel Claudon; Catherine Roy; Florence Mège-Lechevallier; Myriam Decaussin-Petrucci; Marine Dubreuil-Chambardel; Laurent Magaud; Laurent Remontet; Alain Ruffion; Marc Colombel; Sébastien Crouzet; Anne-Marie Schott; Laurent Lemaitre; Muriel Rabilloud; Nicolas Grenier
Journal:  Lancet Oncol       Date:  2018-11-21       Impact factor: 41.316

Review 6.  Novel biomarkers and genomic tests in prostate cancer: a critical analysis.

Authors:  S M Falzarano; M Ferro; E Bollito; E A Klein; G Carrieri; C Magi-Galluzzi
Journal:  Minerva Urol Nefrol       Date:  2015-06-09       Impact factor: 3.720

7.  Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks.

Authors:  Minh Hung Le; Jingyu Chen; Liang Wang; Zhiwei Wang; Wenyu Liu; Kwang-Ting Tim Cheng; Xin Yang
Journal:  Phys Med Biol       Date:  2017-07-24       Impact factor: 3.609

8.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Authors:  J L Donovan; F C Hamdy; J A Lane; D E Neal; M Mason; C Metcalfe; E Walsh; J M Blazeby; T J Peters; P Holding; S Bonnington; T Lennon; L Bradshaw; D Cooper; P Herbert; J Howson; A Jones; N Lyons; E Salter; P Thompson; S Tidball; J Blaikie; C Gray; P Bollina; J Catto; A Doble; A Doherty; D Gillatt; R Kockelbergh; H Kynaston; A Paul; P Powell; S Prescott; D J Rosario; E Rowe; M Davis; E L Turner; R M Martin
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

9.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

10.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.